Energy (J) | Trial | Anterolateral cardioversion proportion | Anteroposterior cardioversion proportion |
70 | Walsh et al25 2005 | 54/150 | 45/144 |
100 | Walsh et al25 2005 | 99/150 | 74/144 |
Brazdzionyte et al24 2006 | 40/55 | 29/48 | |
Schmidt et al26 2021 | 126/233 | 77/234 | |
120 | Siaplaouras et al23 2005 | 47/63 | 47/60 |
150 | Siaplaouras et al23 2005 | 55/63 | 54/60 |
Walsh et al25 2005 | 123/150 | 109/144 | |
Brazdzionyte et al24 2006 | 52/55 | 41/48 | |
Muñoz-Martínez et al15 2010* | 32/46 | 18/45 | |
Schmidt et al26 2021 | 175/233 | 125/234 | |
200 | Siaplaouras et al23 2005 | 60/63 | 57/60 |
Walsh et al25 2005 | 143/150 | 127/144 | |
Brazdzionyte et al24 2006 | 53/55 | 46/48 | |
Muñoz-Martínez et al15 2010, first shock* | 39/46 | 27/45 | |
Muñoz-Martínez et al15 2010, second shock | 41/46 | 32/45 | |
Schmidt et al26 2021 | 200/233 | 162/234 | |
300 | Brazdzionyte et al24 2006 | 54/55 | 47/48 |
360 | Schmidt et al26 2021 | 216/233 | 200/234 |
*Data shared by the author. In the dose–response analyses, we used the first of the two shocks.